Literature DB >> 1680167

CD4+ lymphocyte subsets in the cerebrospinal fluid of multiple sclerosis and non-inflammatory neurological diseases.

M Zaffaroni1, L Gallo, A Ghezzi, C L Cazzullo.   

Abstract

We studied paired cerebrospinal fluid (CSF) and peripheral blood (PB) samples from 18 inactive multiple sclerosis (MS) patients and 10 with non-inflammatory neurological diseases. By means of a dual-colour cytofluorimetric micromethod we were able to count 1500 cells on average in each CSF sample. We found a significant reduction of CD45RA+ and CD4+CD45RA+ cells in the CSF of MS patients. Similarly, CD45RA+ and CD4+CD45RA+ CSF/PB ratios were lower compared with controls. The reduction of suppressor-inducer T-cells did not correlate with CD8+ cell levels in the CSF. The CD4+ subset ratio (CD4+CD45RA-/CD4+CD45RA+) was significantly increased in the CSF of MS patients. Our data suggest that the reduction of CD4+CD45RA+ cells in the PB is not due to a segregation of such cells in the CSF. Conversely, CSF changes reflect changes in the PB similar to these found for other T-cell subsets.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1680167     DOI: 10.1007/bf00314782

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  22 in total

1.  Lymphocyte subsets in the cerebrospinal fluid in active multiple sclerosis.

Authors:  R Salonen; J Ilonen; H Jägerroos; H Syrjälä; T Nurmi; M Reunanen
Journal:  Ann Neurol       Date:  1989-05       Impact factor: 10.422

2.  Decrease of suppressor inducer (CD4+2H4+) T cells in multiple sclerosis cerebrospinal fluid.

Authors:  M Chofflon; H L Weiner; C Morimoto; D A Hafler
Journal:  Ann Neurol       Date:  1989-05       Impact factor: 10.422

3.  Leu-3+ lymphocytes account for increased CSF cellularity.

Authors:  A A Vandenbark; J De Saedeleer; H Heyligen; R Dom; J Raus; J Stragier; H Carton
Journal:  J Neuroimmunol       Date:  1985-05       Impact factor: 3.478

4.  T-cell subsets in multiple sclerosis: relationships between peripheral blood and cerebrospinal fluid.

Authors:  M Zaffaroni; D Caputo; A Ghezzi; C L Cazzullo
Journal:  Acta Neurol Scand       Date:  1985-03       Impact factor: 3.209

Review 5.  Diagnosis and classification of multiple sclerosis.

Authors:  W I McDonald; A M Halliday
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

Review 6.  MS: a CNS and systemic autoimmune disease.

Authors:  D A Hafler; H L Weiner
Journal:  Immunol Today       Date:  1989-03

7.  Monoclonal antibody-defined immunoregulatory cells in multiple sclerosis cerebrospinal fluid.

Authors:  N Cashman; C Martin; J F Eizenbaum; J D Degos; M A Bach
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

8.  T-cell subsets in spinal fluid of multiple sclerosis patients.

Authors:  O R Hommes; C J Brinkman
Journal:  J Neuroimmunol       Date:  1984-04       Impact factor: 3.478

9.  Cerebrospinal fluid and peripheral blood leukocyte subsets in acute inflammation of the CNS.

Authors:  S Bamborschke; W D Heiss
Journal:  J Neurol Sci       Date:  1987-06       Impact factor: 3.181

10.  Acute multiple sclerosis exacerbations are characterized by low cerebrospinal fluid suppressor/cytotoxic T-cells.

Authors:  J Antonen; P Syrjälä; R Oikarinen; H Frey; K Krohn
Journal:  Acta Neurol Scand       Date:  1987-02       Impact factor: 3.209

View more
  1 in total

1.  CD4 subsets (CD45RA/RO) exhibit differences in proliferative responses, IL-2 and gamma-interferon production during intravenous methylprednisolone treatment of multiple sclerosis.

Authors:  A D Crockard; M T Treacy; A G Droogan; S A Hawkins
Journal:  J Neurol       Date:  1996-06       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.